PLA is our software for biostatistical analysis, particularly for measuring potencies of pharmaceuticals in regulated and non-regulated environments. PLA allows the statistical analysis of biological assays according to the European Pharmacopoeia and the US Pharmacopeia. Our customers are primarily biotech and pharmaceutical companies, but also research institutions and regulatory authorities.
With PLA 3.0 you are covering the entire life cycle of your medical product, from development to production and quality control. The software complies with 21 CFR Part 11, GxP and GAMP. Furthermore, PLA is an extensible platform, that you can customize through additional modules to suit your area of application.
Learn more about PLA on our website www.bioassay.de